نتایج جستجو برای: flt3 tyrosine kinase

تعداد نتایج: 262799  

2008
Carola Reindl Ruth Kern Konstantin Petropoulos Vegi M. Naidu Christian Buske Wolfgang Hiddemann Karsten Spiekermann

Purpose: Mutations in the receptor tyrosine kinase FLT3 are found in up to 30% of acute myelogenous leukemia patients and are associated with an inferior prognosis. In this study, we characterized critical tyrosine residues responsible for the transforming potential of active FLT3-receptor mutants and ligand-dependent activation of FLT3-WT. Experimental Design: We performed a detailed structure...

Journal: :Blood 2005
Rebekka Grundler Cornelius Miething Christian Thiede Christian Peschel Justus Duyster

Activating mutations of the Fms-like tyrosine kinase 3 (FLT3) receptor are the most common genetic alteration in acute myeloid leukemia (AML). Two distinct groups of FLT3 mutations are found: internal tandem duplications (ITDs) of the juxtamembrane region and point mutations within the tyrosine kinase domain (TKD). Recently, point mutations within the activation loop of FLT3 have also been desc...

Journal: :Blood 2002
Mark Levis Jeffrey Allebach Kam-Fai Tse Rui Zheng Brenda R Baldwin B Douglas Smith Susan Jones-Bolin Bruce Ruggeri Craig Dionne Donald Small

Constitutively activating internal tandem duplication (ITD) and point mutations of the receptor tyrosine kinase FLT3 are present in up to 41% of patients with acute myeloid leukemia (AML). These FLT3/ITD mutations are likely to be important because their presence is associated with a poor prognosis. Both types of mutations appear to activate the tyrosine kinase activity of FLT3. We describe her...

Journal: :Blood 2007
Deepa B Shankar Junling Li Paul Tapang J Owen McCall Lori J Pease Yujia Dai Ru-Qi Wei Daniel H Albert Jennifer J Bouska Donald J Osterling Jun Guo Patrick A Marcotte Eric F Johnson Niru Soni Kresna Hartandi Michael R Michaelides Steven K Davidsen Saul J Priceman Jenny C Chang Katrin Rhodes Neil Shah Theodore B Moore Kathleen M Sakamoto Keith B Glaser

In 15% to 30% of patients with acute myeloid leukemia (AML), aberrant proliferation is a consequence of a juxtamembrane mutation in the FLT3 gene (FMS-like tyrosine kinase 3-internal tandem duplication [FLT3-ITD]), causing constitutive kinase activity. ABT-869 (a multitargeted receptor tyrosine kinase inhibitor) inhibited the phosphorylation of FLT3, STAT5, and ERK, as well as Pim-1 expression ...

Journal: :Blood 2009
Amanda Nordigården Maria Kraft Pernilla Eliasson Verena Labi Eric W-F Lam Andreas Villunger Jan-Ingvar Jönsson

Constitutively activating internal tandem duplications (ITD) of FLT3 (FMS-like tyrosine kinase 3) are the most common mutations in acute myeloid leukemia (AML) and correlate with poor prognosis. Receptor tyrosine kinase inhibitors targeting FLT3 have developed as attractive treatment options. Because relapses occur after initial responses, identification of FLT3-ITD-mediated signaling events ar...

Journal: :Blood 2006
Elke Heiss Kristina Masson Christina Sundberg Malin Pedersen Jianmin Sun Susanne Bengtsson Lars Rönnstrand

Early signal relay steps upon ligand binding to the receptor tyrosine kinase Flt3 (ie, sites of Flt3 autophosphorylation and subsequent docking partners) are mainly unresolved. By immunoprecipitation of specific tryptic peptides contained in the juxtamembrane region of human Flt3 and subsequent radiosequencing, we identified the tyrosine residues 572, 589, 591, and 599 as in vivo autophosphoryl...

Journal: :Blood 2002
Rui Zheng Alan D Friedman Donald Small

Internal tandem duplication (ITD) mutations of the juxtamembrane domain-coding sequence of the FLT3 gene are found in up to 34% of patients with acute myeloid leukemia (AML) and are associated with a poor prognosis. FLT3/ITDs result in constitutive activation of the tyrosine kinase domain and transform growth factor-dependent cell lines. FLT3 activation leads to antiapoptotic and proliferative ...

2017
Catrin Roolf Nikolaj Dybowski Anett Sekora Stefan Mueller Gudrun Knuebel Andreas Tebbe Hugo Murua Escobar Klaus Godl Christian Junghanss Christoph Schaab

Constitutively activating internal tandem duplication (ITD) alterations of the receptor tyrosine kinase FLT3 (Fms-like tyrosine kinase 3) are common in acute myeloid leukemia (AML) and classifies FLT3 as an attractive therapeutic target. So far, applications of FLT3 small molecule inhibitors have been investigated primarily in FLT3-ITD+ patients. Only recently, a prolonged event-free survival h...

2005
Kyu-Tae Kim Kristin Baird Joon-Young Ahn Paul Meltzer Michael Lilly Mark Levis

Constitutively activating internal tandem duplication (ITD) mutations of the receptor tyrosine kinase FLT3 (Fms-like tyrosine kinase 3) play an important role in leukemogenesis, and their presence is associated with poor prognosis in acute myeloid leukemia (AML). To better understand FLT3 signaling in leukemogenesis, we have examined the changes in gene expression induced by FLT3/ITD or constit...

Journal: :Egyptian Journal of Medical Human Genetics 2021

Abstract Background Acute myeloid leukemia represents the highest percentage of all adult acute variants. Runt-related transcription factor1 ( RUNX1 ), a factor with known tumor suppressor function, was recently reported as promoter in (AML). We investigated role gene expression level Egyptian AML patients and delineated its clinical significance. Results measured using reverse transcription-qu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید